Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
31 studies found for:    " November 21, 2012":" December 21, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Download search resultsDownload the search results for:
" November 21, 2012":" December 21, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION] (31 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Completed An Evaluation of a Rapid Test for HIV
Condition: HIV Seropositivity
Intervention: Device: Rapid testing for HIV
2 Unknown  Veterans Living With HIV/AIDS: A Pilot Study Examining Risk Factors Associated With Self-Directed Violence
Conditions: Human Immunodeficiency Virus Infection(HIV)/Acquired Immunodeficiency Syndrome (AIDS);   Self-Directed Violence
Intervention:
3 Terminated A Safety and Efficacy Study of Amdoxovir in HIV-1 Treatment-experienced Subjects.
Condition: Human Immunodeficiency Virus Infection
Interventions: Drug: amdoxovir 300 mg bid;   Drug: amdoxovir 500 mg bid;   Drug: tenofovir DF 300 mg qd
4 Withdrawn A Safety and Efficacy Study of Amdoxovir in HIV-1 Treatment-experienced Subjects
Condition: Human Immunodeficiency Virus Infection
Interventions: Drug: amdoxovir 300 mg bid;   Drug: amdoxovir 500 mg bid
5 Completed A Randomized Study to Assess the Relative Bioavailability of New Formulations of GSK1265744 Long Acting Parental (LAP) in Healthy Adult Subjects
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: GSK1265744 30 mg oral;   Drug: Midazolam 3 mg oral + GSK1265744 30mg oral;   Drug: GSK1265744 400 mg (200 nm);   Drug: GSK1265744 400 mg (1 micro m);   Drug: GSK1265744 400 mg (5 micro m)
6 Recruiting A Post Marketing Survey Study to Evaluate the Safety and Effectiveness of Prezista
Condition: Acquired Immune Deficiency Syndrome
Intervention: Drug: No intervention
7 Completed A Post Marketing Survey Study to Evaluate the Safety and Effectiveness of Intelence
Condition: Acquired Immune Deficiency Syndrome
Intervention: Drug: No intervention
8 Completed
Has Results
Testing a Community-Friendly Risk Reduction Intervention for Injection Drug Users
Conditions: HIV;   Opioid Dependence
Interventions: Behavioral: Community-friendly Health Recovery Program;   Behavioral: Time-and-Attention-Matched Control Condition
9 Recruiting Secondary HIV Prevention and Adherence Among HIV-infected Drug Users
Conditions: Risk Behavior;   Medication Adherence;   HIV
Interventions: Behavioral: 3H+ (Holistic Health for HIV);   Behavioral: HHRP+ (Holistic Health Recovery Program)
10 Recruiting Does Rosuvastatin Delay Progression of Atherosclerosis in HIV
Conditions: HIV;   Cardiovascular Disease
Interventions: Drug: Rosuvastatin;   Other: Placebo
11 Completed Randomized Control Trial of Shang Ring Versus Forceps-guided Adult Male Circumcision in Southwestern Uganda.
Condition: HIV
Interventions: Procedure: Shang Ring Guided Circumcision;   Procedure: Forceps Guided Circumcision
12 Recruiting Palliative Care in People Living With HIV/AIDS: Integrating Into Standard of Care
Condition: HIV
Interventions: Behavioral: FAmily-CEntered Advance Care Planning;   Behavioral: Healthy Living Control
13 Completed HIV Prevention Among Vulnerable Male Youth
Conditions: Homosexuality, Male;   HIV;   Substance-related Disorders;   Sexual Dysfunctions, Psychological
Interventions: Behavioral: Group-based intervention - Experimental;   Behavioral: Group-based intervention - Control
14 Recruiting Boston Alcohol Research Collaboration on HIV/AIDS (ARCH) Cohort
Conditions: HIV Infection;   Alcohol Use;   Bone Disease;   Substance-Related Disorders
Intervention:
15 Unknown  Atorvastatin for HAART Suboptimal Responders
Condition: Acquired Immune Deficiency Syndrome Virus
Interventions: Other: 'atorvastatin, Lipitor®';   Drug: Placebo
16 Completed A Study to Evaluate the Effects of Calcium Carbonate and Ferrous Fumarate on Pharmacokinetics of Dolutegravir in Healthy Adult Subjects
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: Dolutegravir 50 mg;   Drug: Calcium Carbonate  1200 mg;   Drug: Ferrous Fumarate 324 mg
17 Active, not recruiting An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis
Condition: HIV Infection
Interventions: Behavioral: 3MV;   Behavioral: PCC;   Drug: Emtricitabine/tenofovir (FTC/TDF (Truvada®))
18 Active, not recruiting Behavioral Intervention to Enhance HIV Test/Treat
Condition: HIV/AIDS
Interventions: Behavioral: Infectiousness Risk Reduction;   Behavioral: General Health Improvement
19 Unknown  Assessment of Cognitive Functioning as it Relates to Risk for Suicide in Veterans With HIV/AIDS
Condition: Veterans With HIV/AIDS Diagnosis.
Intervention:
20 Not yet recruiting The Feasibility of Using a General Health Screen to Increase HIV Testing in Community Pharmacies
Conditions: HIV Counseling and Testing;   HIV Infections
Interventions: Behavioral: HIV Test Offer;   Behavioral: General Health Screen Offer

   Previous Page Studies Shown (1-20) Next Page (21-31) Show next page of results    Last Page
Indicates status has not been verified in more than two years